Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution.
Journal
Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
23
08
2023
accepted:
14
11
2023
revised:
07
11
2023
medline:
28
11
2023
pubmed:
28
11
2023
entrez:
27
11
2023
Statut:
aheadofprint
Résumé
T follicular helper (T
Identifiants
pubmed: 38012392
doi: 10.1038/s41375-023-02093-7
pii: 10.1038/s41375-023-02093-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP22K19451, JP21H02945
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP23K15317
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP20J20851
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP23K15316
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP23K15293
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP21K16261
Informations de copyright
© 2023. The Author(s).
Références
Swerdlow SH, Campo E, Pileri SA, Lee Harris N, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.
pubmed: 26980727
pmcid: 4874220
doi: 10.1182/blood-2016-01-643569
Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140:1229–53.
pubmed: 35653592
pmcid: 9479027
doi: 10.1182/blood.2022015851
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48.
pubmed: 35732829
pmcid: 9214472
doi: 10.1038/s41375-022-01620-2
Crotty S. T follicular helper cell biology: a decade of discovery and diseases. Immunity. 2019;50:1132–48.
pubmed: 31117010
pmcid: 6532429
doi: 10.1016/j.immuni.2019.04.011
De Leval L, Rickman DS, Thielen C, De Reynies A, Huang YL, Delsol G, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109:4952–63.
pubmed: 17284527
doi: 10.1182/blood-2006-10-055145
Yi JH, Ryu KJ, Ko YH, Kim WS, Kim SJ. Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma. Cytokine. 2019;113:371–9.
pubmed: 30327172
doi: 10.1016/j.cyto.2018.10.009
Ham JS, Park HY, Ryu KJ, Ko YH, Kim WS, Kim SJ. Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma. Oncotarget. 2017;8:76231–40.
pubmed: 29100307
pmcid: 5652701
doi: 10.18632/oncotarget.19301
Vose JM, Neumann M, Harris ME. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project. J Clin Oncol. 2008;26:4124–30.
pubmed: 18626005
doi: 10.1200/JCO.2008.16.4558
Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, et al. Toward understanding and exploiting tumor heterogeneity. Nat Med. 2015;21:846–53.
pubmed: 26248267
pmcid: 4785013
doi: 10.1038/nm.3915
Fujisawa M, Sakata-Yanagimoto M, Nishizawa S, Komori D, Gershon P, Kiryu M, et al. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma. Leukemia. 2018;32:694–702.
pubmed: 28832024
doi: 10.1038/leu.2017.273
Ambesi-Impiombato A, Couronné L, Quinn SA, Kim CS, da Silva Almeida AC, et al. RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis. Cancer Cell. 2018;33:259–273.e7.
pubmed: 29398449
pmcid: 5811310
doi: 10.1016/j.ccell.2018.01.001
Ng SY, Brown L, Stevenson K, DeSouza T, Aster JC, Louissaint A, et al. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. Blood. 2018;132:935–47.
pubmed: 29769264
pmcid: 10251505
doi: 10.1182/blood-2017-11-818617
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541–50.
pubmed: 29686425
pmcid: 5998822
doi: 10.1038/s41591-018-0014-x
Niino D, Komohara Y, Murayama T, Aoki R, Kimura Y, Hashikawa K, et al. Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol Int. 2010;60:278–83.
pubmed: 20403029
doi: 10.1111/j.1440-1827.2010.02514.x
Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026–36.
pubmed: 19965671
pmcid: 2817630
doi: 10.1182/blood-2009-06-227579
Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31.
pubmed: 32377375
pmcid: 7197635
doi: 10.1038/s41421-020-0168-9
Yabe M, Gao Q, Ozkaya N, Huet S, Lewis N, Pichardo JD, et al. Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma. Blood Cancer J. 2020;10:32.
pubmed: 32144240
pmcid: 7060322
doi: 10.1038/s41408-020-0301-x
Fujisawa M, Nguyen TB, Abe Y, Suehara Y, Fukumoto K, Suma S, et al. Clonal germinal center B cells function as a niche for T-cell lymphoma. Blood. 2022;140:1937–50.
pubmed: 35921527
pmcid: 10653021
doi: 10.1182/blood.2022015451
Abe Y, Sakata-Yanagimoto M, Fujisawa M, Miyoshi H, Suehara Y, Hattori K, et al. A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling. Nat Cell Biol. 2022;24:565–78.
pubmed: 35332263
pmcid: 9033586
doi: 10.1038/s41556-022-00866-3
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.
pubmed: 20644199
pmcid: 2928508
doi: 10.1101/gr.107524.110
Schapiro D, Jackson HW, Raghuraman S, Fischer JR, Zanotelli VRT, Schulz D, et al. histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods. 2017;14:873–6.
pubmed: 28783155
pmcid: 5617107
doi: 10.1038/nmeth.4391
Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16:278.
pubmed: 26653891
pmcid: 4676162
doi: 10.1186/s13059-015-0844-5
Dong D, Zheng L, Lin J, Zhang B, Zhu Y, Li N, et al. Structural basis of assembly of the human T cell receptor-CD3 complex. Nature. 2019;573:546–52.
pubmed: 31461748
doi: 10.1038/s41586-019-1537-0
Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46:171–5.
pubmed: 24413737
doi: 10.1038/ng.2872
Cairns RA, Iqbal J, Lemonnier F, Kucuk C, De Leval L, Jais JP, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119:1901–3.
pubmed: 22215888
pmcid: 3293643
doi: 10.1182/blood-2011-11-391748
Couronné L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012;366:95–6.
pubmed: 22216861
doi: 10.1056/NEJMc1111708
Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with T FH-like features and adverse clinical parameters. Blood. 2012;120:1466–9.
pubmed: 22760778
doi: 10.1182/blood-2012-02-408542
Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019;133:1664–76.
pubmed: 30782609
pmcid: 6460420
doi: 10.1182/blood-2018-09-872549
Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.
doi: 10.1186/1471-2105-14-7
Weinstein JS, Lezon-Geyda K, Maksimova Y, Craft S, Zhang Y, Su M, et al. Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes. Blood. 2014;124:3719–29.
pubmed: 25331115
pmcid: 4263981
doi: 10.1182/blood-2014-06-582700
Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24:978–85.
pubmed: 29942094
doi: 10.1038/s41591-018-0045-3
Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496–502.
pubmed: 30787437
pmcid: 6434952
doi: 10.1038/s41586-019-0969-x
Vallois D, Dobay MPD, Morin RD, Lemonnier F, Missiaglia E, Juilland M, et al. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. Blood. 2016;128:1490–502.
pubmed: 27369867
doi: 10.1182/blood-2016-02-698977
Petti AA, Williams SR, Miller CA, Fiddes IT, Srivatsan SN, Chen DY, et al. A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nat Commun. 2019;10:3660.
pubmed: 31413257
pmcid: 6694122
doi: 10.1038/s41467-019-11591-1
Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189–96.
pubmed: 27124452
pmcid: 4944528
doi: 10.1126/science.aad0501
Peng J, Sun B-F, Chen C-Y, Zhou J-Y, Chen Y-S, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725–38.
pubmed: 31273297
pmcid: 6796938
doi: 10.1038/s41422-019-0195-y
Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 2015;15:486–99.
van der Leun AM, Thommen DS, Schumacher TN. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20:218–32.
pubmed: 32024970
pmcid: 7115982
doi: 10.1038/s41568-019-0235-4
Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163–72.
pubmed: 30643263
pmcid: 6340744
doi: 10.1038/s41590-018-0276-y
Zhang L, Yu X, Zheng L, Zhang Y, Li Y, Fang Q, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564:268–72.
pubmed: 30479382
doi: 10.1038/s41586-018-0694-x
Pritchett JC, Yang Z-Z, Kim HJ, Villasboas JC, Tang X, Jalali S, et al. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL). Leukemia. 2022;36:165–76.
pubmed: 34230608
doi: 10.1038/s41375-021-01321-2
Sakaguchi S, Mikami N, Wing JB, Tanaka A, Ichiyama K, Ohkura N. Regulatory T Cells and Human Disease. Annu Rev Immunol. 2020;38:541–66.
pubmed: 32017635
doi: 10.1146/annurev-immunol-042718-041717
Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792–809.e23.
pubmed: 33545035
doi: 10.1016/j.cell.2021.01.010
Villani A-C, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356:eaah4573.
Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184:2988–3005.e16.
pubmed: 34019793
pmcid: 8479759
doi: 10.1016/j.cell.2021.04.038
Maier B, Leader AM, Chen ST, Tung N, Chang C, LeBerichel J, et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature. 2020;580:257–62.
pubmed: 32269339
pmcid: 7787191
doi: 10.1038/s41586-020-2134-y
Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci. 2006;97:1139–46.
pubmed: 16952304
doi: 10.1111/j.1349-7006.2006.00307.x
Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O’Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205:1797–805.
pubmed: 18625747
pmcid: 2525604
doi: 10.1084/jem.20072683
Kardava L, Moir S, Wang W, Ho J, Buckner CM, Posada JG, et al. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J Clin Invest. 2011;121:2614–24.
pubmed: 21633172
pmcid: 3127436
doi: 10.1172/JCI45685
Warnatz K, Wehr C, Dräger R, Schmidt S, Eibel H, Schlesier M, et al. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology. 2002;206:502–13.
pubmed: 12607725
doi: 10.1078/0171-2985-00198
Ehrhardt GRA, Hijikata A, Kitamura H, Ohara O, Wang J-Y, Cooper MD. Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med. 2008;205:1807–17.
pubmed: 18625746
pmcid: 2525601
doi: 10.1084/jem.20072682
Subedi N, Verhagen LP, Bosman EM, van Roessel I, Tel J. Understanding natural killer cell biology from a single cell perspective. Cell Immunol. 2022;373:104497.
pubmed: 35248938
doi: 10.1016/j.cellimm.2022.104497
Shimasaki N, Jain A, Campana D. NK cells for cancer immunotherapy. Nat Rev Drug Discov. 2020;19:200–18.
pubmed: 31907401
doi: 10.1038/s41573-019-0052-1
Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E, et al. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood. 2005;106:1711–7.
pubmed: 15886320
doi: 10.1182/blood-2005-03-0918
Garcia-Alonso L, Handfield L-F, Roberts K, Nikolakopoulou K, Fernando RC, Gardner L, et al. Mapping the temporal and spatial dynamics of the human endometrium in vivo and in vitro. Nat Genet. 2021;53:1698–711.
pubmed: 34857954
pmcid: 8648563
doi: 10.1038/s41588-021-00972-2
Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17:159–62.
pubmed: 31819264
doi: 10.1038/s41592-019-0667-5
Loghavi S, Wang SA, Jeffrey Medeiros L, Jorgensen JL, Li X, Xu-Monette ZY, et al. Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology. Leuk Lymphoma. 2016;57:2804–12.
pubmed: 27105079
pmcid: 5142610
doi: 10.3109/10428194.2016.1170827
Hwang J-R, Byeon Y, Kim D, Park S-G. Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp Mol Med. 2020;52:750–61.
pubmed: 32439954
pmcid: 7272404
doi: 10.1038/s12276-020-0435-8
Lin CS, Park T, Chen ZP, Leavitt J. Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells. J Biol Chem. 1993;268:2781–92.
pubmed: 8428952
doi: 10.1016/S0021-9258(18)53842-4
Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med. 2003;197:1477–88.
pubmed: 12782714
pmcid: 2193901
doi: 10.1084/jem.20021726